India to manufacture 100mn doses a year of Sputnik: Moscow institute

Phase 3 clinical trials of the vaccine are approved and ongoing in Belarus, the UAE, Venezuela and other countries, and Phase 2/3 have been approved in India. India, along with Brazil, China, South Korea and others, will provide the vaccine to at least 50 countries that have requested over 1.2 billion doses.

from Hindustan Times - india https://ift.tt/3mewGF3

Share: